These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 8839787)
1. Estradiol regulates tumor growth by influencing p53 and bcl-2 expression in human endometrial adenocarcinomas grown in nude mice. Horvath G; Leser G; Karlsson L; Delle U In Vivo; 1996; 10(4):411-6. PubMed ID: 8839787 [TBL] [Abstract][Full Text] [Related]
2. Effect of estradiol on tumor growth, cell kinetics and p53 oncoprotein expression in human endometrial adenocarcinoma heterotransplanted into nude mice. Horvath G; Baldetorp B; Fernö M; Johansson M; Nesland J; Tropé C In Vivo; 1993; 7(5):451-6. PubMed ID: 8110990 [TBL] [Abstract][Full Text] [Related]
3. Characterisation of a human endometrial adenocarcinoma established in vivo and in vitro. Karlsson L; Leser G; Ryd W; Delle U; Köpf I; Horvath G In Vivo; 1996; 10(4):421-8. PubMed ID: 8839789 [TBL] [Abstract][Full Text] [Related]
4. Estradiol influences p53 expression in a human endometrial adenocarcinoma heterotransplanted into nude mice. Horvath G; Leser G; Delle U In Vivo; 1996; 10(1):29-32. PubMed ID: 8726808 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
6. Estradiol induced changes in tumor growth and steroid receptor content in a heterotransplanted human endometrial adenocarcinoma. Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J In Vivo; 1991; 5(4):401-6. PubMed ID: 1810429 [TBL] [Abstract][Full Text] [Related]
7. bcl-2 and p53 in endometrial adenocarcinoma. Taskin M; Lallas TA; Barber HR; Shevchuk MM Mod Pathol; 1997 Jul; 10(7):728-34. PubMed ID: 9237185 [TBL] [Abstract][Full Text] [Related]
8. Progression of human endometrial adenocarcinoma heterotransplanted into nude mice from hormone-sensitive to hormone resistant growth. Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J In Vivo; 1991; 5(2):185-90. PubMed ID: 1768790 [TBL] [Abstract][Full Text] [Related]
9. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo]. Ji YB; Zhou JH; Zuo MX; You QD Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773 [TBL] [Abstract][Full Text] [Related]
10. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751 [TBL] [Abstract][Full Text] [Related]
11. Estradiol induces DNA fragmentation in a human endometrial adenocarcinoma with estradiol-inhibited growth phenotype. Karlsson L; Leser G; Ryd W; Horvath G Anticancer Res; 1997; 17(5A):3259-63. PubMed ID: 9413157 [TBL] [Abstract][Full Text] [Related]
12. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice. Truchet I; Jozan S; Guerrin M; Mazzolini L; Vidal S; Valette A Exp Cell Res; 2000 Feb; 254(2):241-8. PubMed ID: 10640422 [TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells. Pratt MA; White D; Kushwaha N; Tibbo E; Niu MY Apoptosis; 2007 Apr; 12(4):657-69. PubMed ID: 17252199 [TBL] [Abstract][Full Text] [Related]
14. Estradiol-17beta regulates vascular endothelial growth factor and Bcl-2 expression in HHUA cells. Zhi X; Honda K; Sumi T; Yasui T; Nobeyama H; Yoshida H; Ishiko O Int J Oncol; 2007 Dec; 31(6):1333-8. PubMed ID: 17982659 [TBL] [Abstract][Full Text] [Related]
15. Protein expression of p53 and Rb suppressor genes during the first passages of human endometrial adenocarcinomas heterotransplanted into nude mice. Horvath G; Leser G; Delle U In Vivo; 1995; 9(1):41-8. PubMed ID: 7669947 [TBL] [Abstract][Full Text] [Related]
16. BCL-2 and P53 expression in endometrial carcinoma. Erkanli S; Eren F; Pekin S; Bagis T J Exp Clin Cancer Res; 2004 Mar; 23(1):97-103. PubMed ID: 15149157 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289 [TBL] [Abstract][Full Text] [Related]
19. Growth interaction between different tumor populations in human endometrial adenocarcinoma growing in nude mice. Horvath G; Fernö M; Baldetorp B; Johansson M In Vivo; 1993; 7(6A):511-7. PubMed ID: 8193269 [TBL] [Abstract][Full Text] [Related]
20. Tumor volume growth and cell proliferation in an estradiol resistant human endometrial adenocarcinoma growing in nude mice. Horvath G; Andersson H; Mellqvist L; Leser G; Delle U In Vivo; 1994; 8(2):259-62. PubMed ID: 7919131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]